Here, we show that the dynamic regulation of NRF2 stability and antioxidant signaling requires TRIP12, an essential E3 ligase that is dysregulated in Parkinson’s disease, a pathology that is characterized by aberrant ROS management. The gene discussed is NFE2L2; the disease is Parkinson disease.